Breast Cancer

Health Plus will promote breast cancer awareness at the VU Benefits Open House on Wednesday, Oct. 23. Read More

The Think Pink! Breast Cancer Awareness Expo is scheduled from 11 a.m. to 1 p.m. Wednesday, Oct. 2, in the Light Hall North Lobby. Visit the expo to learn about breast cancer prevention, screenings and more. Read More

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells. Read More

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk. Read More

The finding gives a boost to the field of metabolomics, the next big thing in fighting cancer. It can complement immunotherapies, which use the body’s natural defenses to kill cancer cells. Read More

Learning you have dense breasts can prompt many questions, including how this affects your risk of breast cancer. Read More

An international coalition led by scientists at Vanderbilt University Medical Center and the QIMR Berghofer Medical Research Institute in Herston, Australia, has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer. Read More

  Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Ben Ho Park, MD,… Read More

A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer. Read More

Patients at high risk for developing breast cancer can now be seen by a team of breast health experts in Cool Springs. The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for high-risk individuals. Read More

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. Read More

Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast. Read More

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Read More

Do you know what it means to be at “high” or “elevated” risk for developing breast cancer? Do you know if you are at high risk? Read More

The Think Pink! Breast Cancer Awareness Expo will be held Wednesday, Oct. 4, from 11 a.m. to 1 p.m. in the Light Hall North Lobby. Read More

Are you a breast cancer survivor? Health & Wellness would like to celebrate you and support breast cancer awareness by creating an “Awareness Saves Lives” faculty and staff survivor banner. Read More

Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers. Read More

New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes. Read More

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. Read More

Vanderbilt University engineers find existing human protein is ideal carrier for powerful molecules that can signal tumors to self-destruct. Read More